Related Experiment Video

Updated: Jun 10, 2026

Flow Cytometry Analysis of Immune Cells Within Murine Aortas
15:15

Flow Cytometry Analysis of Immune Cells Within Murine Aortas

Published on: July 1, 2011

[The implication of Chlamydia pneumoniae in damage to human aortic endotheliocytes in atherosclerosis]

A I Lysenko, N A Solov'eva

    Arkhiv Patologii
    |August 12, 2010
    PubMed

    Insights

    Chlamydia pneumoniae (CP) infection was found in over half of deceased patients, damaging endothelial cells and potentially initiating atherosclerosis. This bacterium contributes to plaque erosion and destabilization, impacting cardiovascular health.

    Area of Science:

    • Pathology
    • Microbiology
    • Cardiovascular Science

    Context:

    • Investigated endothelial cell Chlamydia pneumoniae (CP) presence in aortic intima of deceased patients.
    • Detected CP in 56.5% of cases, including unaffected areas (19.6%).
    • Described three morphological forms of CP and its complete life cycle within endothelial cells.

    Purpose:

    • To investigate the role of Chlamydia pneumoniae in endothelial cell pathology.
    • To elucidate the mechanism of endothelial cell destruction by CP.
    • To explore the link between CP infection and atherosclerosis development.

    Summary:

    • Cytological examination revealed Chlamydia pneumoniae (CP) in endothelial cells of 56.5% of 46 deceased patients.
    • Observed the full CP life cycle, leading to aponecrotic death of endothelial cells above fatty streaks and plaques.
    • Focal destruction by CP caused intimal erosion and thrombogenesis, suggesting a role in atherosclerosis initiation and progression.

    Impact:

    • Demonstrates CP's direct role in endothelial cell damage and apoptosis.
    • Highlights CP-induced intimal erosion as a potential trigger for thrombogenesis.
    • Suggests Chlamydia pneumoniae infection as a significant factor in atherosclerosis initiation, progression, and plaque destabilization.

    Related Concept Videos

    Atherosclerosis I: Introduction01:30

    Atherosclerosis I: Introduction

    Atherosclerosis is a progressive disorder characterized by the buildup of plaques on the arterial inner wall, causing them to narrow and harden over time. These plaques comprise lipids, calcium, blood components, carbohydrates, and fibrous tissue. The process primarily affects the intima of large and medium-sized arteries, reducing blood flow in any artery.Etiology and risk factorsThe cause of atherosclerosis is multifactorial, involving a complex interplay among endothelial injury, lipid...
    Coronary Artery Disease II: Pathophysiology01:26

    Coronary Artery Disease II: Pathophysiology

    Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...
    Peripheral Artery Disease I: Introduction01:30

    Peripheral Artery Disease I: Introduction

    Peripheral artery disease (PAD) predominantly results from atherosclerosis, which involves the accumulation of fatty deposits, or plaques, within the walls of arteries. This causes them to narrow and harden, significantly reducing blood flow. PAD predominantly affects the legs, particularly the arteries supplying the thighs and calves. In rare cases, it may involve other arteries, including those in the arms.Etiology of PAD:The principal cause of PAD is atherosclerosis, which results from fatty...
    Coronary Artery Disease I: Introduction01:30

    Coronary Artery Disease I: Introduction

    Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
    Atherosclerosis II: Clinical Manifestations and Diagnostic Tests01:27

    Atherosclerosis II: Clinical Manifestations and Diagnostic Tests

    Atherosclerosis is a progressive disorder that leads to the thickening and narrowing of arterial walls due to plaque buildup. This condition can cause various symptoms depending on the arteries affected:Coronary Artery Disease (CAD): This condition affects the coronary arteries and may lead to chest pain (angina), shortness of breath (dyspnea), heart attacks, and other heart disease symptoms.Cerebrovascular Disease: This affects blood flow to the brain, causing transient ischemic attacks (TIAs)...
    Inflammation01:38

    Inflammation

    Overview